Medistim ASA Market Cap ($590.32 Million)
Market Cap & Net Worth: Medistim ASA (MEDI)
Medistim ASA market cap. Medistim ASA (OL:MEDI) has a market capitalization of $590.32 Million (Nkr5.61 Billion) as of October 31, 2026. Listed on the OL stock exchange, this Norway-based company holds position #11119 globally and #85 in its home market, demonstrating a 6.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medistim ASA's stock price Nkr307.00 by its total outstanding shares 18273093 (18.27 Million).
Medistim ASA Market Cap History (2015–2026)
Medistim ASA market cap history from 2015 to 2026. Data shows growth from $86.07 Million to $590.32 Million (20.31% CAGR). Check Medistim ASA stock price for real-time trading data and today's change.
Medistim ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medistim ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Medistim ASA (MEDI) cash conversion ratio for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.51x
Medistim ASA's market cap is 0.51 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.77x
Medistim ASA's market cap is 2.77 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $86.07 Million | $249.97 Million | $40.42 Million | 0.34x | 2.13x |
| 2016 | $121.81 Million | $262.67 Million | $39.10 Million | 0.46x | 3.12x |
| 2017 | $122.39 Million | $296.05 Million | $47.57 Million | 0.41x | 2.57x |
| 2018 | $123.67 Million | $323.01 Million | $57.05 Million | 0.38x | 2.17x |
| 2019 | $340.98 Million | $356.91 Million | $70.31 Million | 0.96x | 4.85x |
| 2020 | $449.50 Million | $356.21 Million | $69.39 Million | 1.26x | 6.48x |
| 2021 | $668.51 Million | $417.82 Million | $90.90 Million | 1.60x | 7.35x |
| 2022 | $426.38 Million | $491.94 Million | $113.97 Million | 0.87x | 3.74x |
| 2023 | $401.32 Million | $526.36 Million | $103.82 Million | 0.76x | 3.87x |
| 2024 | $287.47 Million | $562.60 Million | $103.83 Million | 0.51x | 2.77x |
Competitor Companies of MEDI by Market Capitalization
Companies near Medistim ASA in the global market cap rankings as of October 31, 2026. See Medistim ASA (MEDI) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to Medistim ASA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #119 globally with a market cap of $181.83 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.58 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #119 | Abbott Laboratories | NYSE:ABT | $181.83 Billion | $104.57 |
| #204 | Stryker Corporation | NYSE:SYK | $119.58 Billion | $311.75 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $97.11 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Medistim ASA (2015–2026)
Market capitalization of Medistim ASA from 2015 to today. Between 2015 and today, Medistim ASA's market cap moved from $86.07 Million to $ 590.32 Million, with a yearly change of 20.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr590.32 Million | +18.53% |
| 2025 | Nkr498.02 Million | +73.24% |
| 2024 | Nkr287.47 Million | -28.37% |
| 2023 | Nkr401.32 Million | -5.88% |
| 2022 | Nkr426.38 Million | -36.22% |
| 2021 | Nkr668.51 Million | +48.72% |
| 2020 | Nkr449.50 Million | +31.83% |
| 2019 | Nkr340.98 Million | +175.72% |
| 2018 | Nkr123.67 Million | +1.05% |
| 2017 | Nkr122.39 Million | +0.47% |
| 2016 | Nkr121.81 Million | +41.53% |
| 2015 | Nkr86.07 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Medistim ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $590.32 Million USD |
| MoneyControl | $590.32 Million USD |
| MarketWatch | $590.32 Million USD |
| marketcap.company | $590.32 Million USD |
| Reuters | $590.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more